http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6844167-B2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1241 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 |
| filingDate | 2002-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786e7ab81751a8bb7c0764e70b0b5abb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a9e633da8e3adbd068062fbcbe7a964 |
| publicationDate | 2005-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6844167-B2 |
| titleOfInvention | Pharmacological targeting of mRNA cap formation for treatment of parasitic infections |
| abstract | This invention provides the genes encoding the RNA triphosphatase and RNA guanylyltransferase of the malaria parasite Plasmodium falciparum and the catalytically active recombinant RNA triphosphatase and RNA guanylyltransferase enzymes. These enzymes form the basis of activity inhibition assays to identify molecules that specifically target the formation of the mRNA 5′ cap in unicellular eukaryotic parasites. |
| priorityDate | 2000-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 376.